Prostate Adenocarcinoma

Showing NaN - NaN of 13

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Prostate Cancer, Prostate Adenocarcinoma Trial in Worldwide (Cabozantinib, Atezolizumab, Abiraterone Acetate)

Recruiting
  • Metastatic Prostate Cancer
  • Prostate Adenocarcinoma
  • Tucson, Arizona
  • +259 more
Oct 19, 2022

Prostate Adenocarcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in United States

Recruiting
  • Prostate Adenocarcinoma
  • +6 more
  • Gonadotrophin Releasing Hormone
  • +2 more
  • Gilbert, Arizona
  • +86 more
Sep 27, 2022

Prostate Cancer, Prostate Adenocarcinoma Trial in Canada, United States (Radical Prostatectomy, TULSA Procedure)

Recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • Radical Prostatectomy
  • TULSA Procedure
  • Tarzana, California
  • +7 more
Aug 10, 2022

Localized Prostate Carcinoma, Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8 Trial in United States (Apalutamide,

Recruiting
  • Localized Prostate Carcinoma
  • +8 more
  • Tucson, Arizona
  • +4 more
Jun 28, 2022

Prostate Adenocarcinoma, Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma Trial in Canada, Switzerland, United

Active, not recruiting
  • Prostate Adenocarcinoma
  • +3 more
  • Hypofractionated radiation therapy
  • +2 more
  • Birmingham, Alabama
  • +240 more
Jun 6, 2022

Prostate Adenocarcinoma, Obesity, Morbid Trial in Baltimore (device, behavioral, drug)

Withdrawn
  • Prostate Adenocarcinoma
  • Obesity, Morbid
  • Bead Block 300-500 um
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins School of Medicine - Sidney Kimmel Comprehensive C
Apr 29, 2022

Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in United States (Laboratory

Completed
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Washington, District of Columbia
  • +19 more
Aug 13, 2018

Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Baltimore (Dexamethasone,

Terminated
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Jul 11, 2018

Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in United States (drug, other, procedure)

Completed
  • Prostate Adenocarcinoma
  • +4 more
  • Los Angeles, California
  • +14 more
Sep 18, 2017

Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in United States (drug, other,

Terminated
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Jacksonville, Florida
  • +13 more
Aug 21, 2017